Meeting
2018 Genitourinary Cancers Symposium
Evaluation of the MiCheck MIA test performance in differentiating aggressive from non-aggressive prostate cancer: The MiCheck-01 prospective trial.
Authors
Neal D. Shore
Carolina Urologic Research Center, Myrtle Beach, SC
Neal D. Shore , Christopher Michael Pieczonka , Ralph Jonathan Henderson , James L. Bailen , Jennifer Lynn Beebe-Dimmer , Julie J. Ruterbusch , Daniel R. Saltzstein , Raoul S. Concepcion , Robert Borotkanics , Rachel Levin , Sandra Wissmueller , Douglas Campbell , Brad Walsh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr TPS152)
DOI
10.1200/JCO.2018.36.6_suppl.TPS152
Abstract #
TPS152
Poster Bd #
N15
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
MRI-transrectal ultrasound cognitive fusion-targeted transperineal template-guided saturation prostate biopsies in a consecutive cohort of men.
First Author: Haim Matzkin
Poster
2019 Genitourinary Cancers Symposium
The effect of urologic oncology fellowship training on type and yield of prostate biopsy.
First Author: Molly Elmer DeWitt-Foy
Poster
2016 Genitourinary Cancers Symposium
Association of changing prostate-specific antigen (PSA) levels on repeat testing with lower risk for Gleason Score (GS) ≥ 7 prostate cancer.
First Author: Tobias Nordström
Poster
2016 Genitourinary Cancers Symposium
The risk-based STHLM3 model to improve prostate cancer testing in men 50-69 years: Further health, economic, and clinic evaluation.
First Author: Henrik Gronberg